This study aimed to clarify whether Gram-positive (G+) and Gram-negative (G2) bacteria affect antigen-presenting cells differently and thereby influence the immunogenicity of proteins they express. Lactobacilli, lactococci and Escherichia coli strains were transformed with plasmids conferring intracellular ovalbumin (OVA) production. Murine splenic antigen presenting cells (APCs) were pulsed with washed and UV-inactivated OVA-producing bacteria, control bacteria, or soluble OVA. The ability of the APCs to activate OVA-specific DO11.10 CD4 + T cells was assessed by measurments of T cell proliferation and cytokine (IFN-c, IL-13, IL-17, IL-10) production. OVA expressed within E. coli was strongly immunogenic, since 500 times higher concentrations of soluble OVA were needed to achieve a similar level of OVA-specific T cell proliferation. Furthermore, T cells responding to soluble OVA produced mainly IL-13, while T cells responding to E. coliexpressed OVA produced high levels of both IFN-c and IL-13. Compared to E. coli, G+ lactobacilli and lactococci were poor inducers of OVA-specific T cell proliferation and cytokine production, despite efficient intracellular expression and production of OVA and despite being efficiently phagocytosed. These results demonstrate a pronounced difference in immunogenicity of intracellular antigens in G+ and G2 bacteria and may be relevant for the use of bacterial carriers in vaccine development.
Introduction
Antigen-presenting cells (APCs) represent a link between innate and adaptive immunity by taking up soluble or particulate antigen and presenting them to T cells. Due to their effects on antigenpresenting cells, microbial antigens are typically more immunogenic than soluble non-microbial antigens, e.g. simple food proteins [1] . Firstly, antigens in the particulate format, such as microbes, are generally taken up more readily than soluble antigens by APCs [2, 3] . Secondly, conserved microbial structures, ''danger signals'', stimulate pattern recognition receptors, leading to activation of the antigen-presenting cell with ensuing production of T cell activating cytokines and expression of co-stimulatory molecules. These signals promote activation, proliferation and cytokine production of naïve T cells that recognize their cognate antigen on the APC, while an encounter of the same antigen in the absence of such co-stimulatory signals results in T cell anergy [4, 5] .
Gram-positive (G+) bacteria have a thick and rigid cell wall consisting of up to 50 layers of peptidoglycan along with teichoic acid, lipoteichoic acids, lipoproteins and other constituents whereas Gram-negative (G2) bacteria have a very thin peptidoglycan layer and an outer membrane that contains LPS and lipoproteins. LPS, peptidoglycan, lipoproteins, and lipotechoic acids are recognized by pattern recognition receptors (PPRs), many of which are expressed on different subsets of APCs [6] . In monocytes, intact G+ bacteria induce higher levels of IL-12 and TNF production than do G2 bacteria, while the latter induce higher levels of IL-10 and PGE 2 [7, 8, 9, 10] . Conversely, human monocytes that have been differentiated in vitro into dendritic cells (DCs) produce similar levels of IL-12 and TNF in response to G+ and G2 bacteria [11, 12, 13] . Furthermore, G2 bacteria are more potent than G+ bacteria in promoting the up-regulation of co-stimulatory molecules on monocyte-derived DCs [12, 13] . Presentation of unrelated antigens by DC to T cells is known to be enhanced by bacterial-induced maturation, and, in particular G2 bacteria, have been shown to promote Th1 polarisation [13, 14, 15] .
Despite these recognized differences in reactions of APCs to G+ and G2 bacteria, little is known regarding how this affects the ability of APCs to boost and modulate T cell responses to an antigen expressed within the bacterium. To address this question, we cloned a fragment of the gene encoding the model antigen ovalbumin (OVA) into plasmids enabling its production intracellularly in G+ (Lactobacillus sakei, Lactobacillus plantarum, and Lactococcus lactis) and G2 (Escherichia coli) bacteria. OVA-transformed bacteria, or soluble OVA, were fed to DCs derived from mouse spleen followed by assessment of proliferation and cytokine production by transgenic OVA-specific CD4 + T cells.
Materials and Methods

Ethics Statement
The experiments were carried out according to the guidelines of the 'Council of Europe Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific purposes'. The study was approved by the Regional Ethics Committee, University of Gothenburg (Permit Number: 408-2008).
Bacterial Strains and Media
The bacterial strains used in this study are listed in Table 1 . E. coli HB101 (Promega, Madison, WI) was used as the host strain for a plasmid that encodes full-length ovalbumin (OVA), whereas Lactobacillus sakei Lb790 [16] , Lactobacillus plantarum NC8 [17] , Lactococcus lactis MG1363 [18] , and E. coli XL10 Gold (Stratagene) were used as hosts for vectors encoding an immunodominant OVA fragment (OVA f ) or green fluorescent protein (GFP). E. coli bacteria were grown at 37uC on BHI agar or in BHI broth (Oxoid, Basingstoke, UK) with shaking. Lactobacilli were cultured on MRS agar or in MRS broth (Oxoid). Lactococci were grown at 30uC on M17 agar or in static M17 broth (Oxoid) supplemented with 0.5% glucose. When appropriate, antibiotics were added to the growth medium, i.e., 200 mg/ml erythromycin, 15 mg/ml chloamphenicol or 100 mg/ml ampicillin for E. coli, and 10 mg/ml erythromycin for the lactobacilli and lactococci.
Construction of OVA-producing Bacteria
The plasmids used in the present study are listed in Table 1 . Plasmid DNA was isolated using the QIAprep Miniprep kit (Qiagen, Hilden, Germany), and recombinant plasmids were constructed by cloning [19] using restriction enzymes and T4 DNA ligase (Promega and New England Biolabs) and appropriate primers (MWG-Biotech AG, Ebersberg, Germany). PCR analyses were performed with the Gene Amp PCR System 9700 (PerkinElmer Biosystem) and Expand High Fidelity PCR System Polymerase (Roche Diagnostics). Details regarding construction of the plasmids are found in Methods S1.
E. coli Producing Full-length OVA Protein
Production of OVA by the recombinant E. coli was verified by Western blotting of sonicated overnight cultures (2 min, amplitude: 60, Vibra-Cell ultrasonic processor; Sonics & Materials Inc., Newtown, CT). The sonicates, soluble OVA (Sigma Chemical Co., St Louis, MO), and a molecular mass marker (LMW electrophoresis calibration kit; Phamacia Biotech, Uppsala, Sweden) were separated by SDS-PAGE, transferred to nylon membranes, blocked with 2% donkey serum, treated with avidinbiotin (Vector Laboratories, Burlingame, CA), and stained with goat-anti-OVA antibodies (1:2,000; Cappel, Durham, NC), followed by biotinylated donkey anti-goat-IgG antibodies (1:5,000; Jackson Laboratories, West Grove, PA), ABC/HRP (DAKO, Glostrup, Denmark), and 0.5 mg/ml of the substrate diaminbenzidine (DAB) (Sigma).
The levels of full-length OVA produced by E. coli bacteria were also quantified by ELISA. Costar plates (Invitrogen, San Diego, CA) were coated with rabbit anti-ovalbumin antibody (1:500; Immunology Consultants Laboratory, Newberg, OR) and blocked with 5% BSA (Sigma). Sonicated bacteria or OVA standard (Sigma) were diluted and detected using anti-ovalbumin HRP (1:60,000; Nordic BioSite, Tä by, Sweden), followed by tetramethylbenzidene (TMB) substrate (Sigma). The reaction was stopped with 1 M H 2 SO 4 , and the optical density of the solution was measured spectrophotometrically at 450 nm (Molecular Devices Corporation, Sunnyvale, CA).
Construction of Lactobacilli, Lactococci, and E. coli Producing a Synthetic OVA Fragment or GFP A synthetic gene that encodes amino acids 319-386 of chicken ovalbumin (termed OVA fragment; OVA f ), and which was adapted with respect to the codon usage of lactobacilli (Fig. S1) , was generated. The gene was flanked by the restriction sites NcoI (start codon) and XhoI, and was inserted into the multiple cloning site of the pUC57 plasmid (GeneScripts Corp., Piscataway, NJ). Details regarding the construction of plasmids are found in Methods S1.
Production of the OVA fragment was semiquantitatively estimated by SDS-PAGE. Transformed bacteria were sonicated with glass beads (#106 mm; Sigma) [20] , and 350 ng of bacterial proteins, as determined using the NanoDrop system (NanoDrop, Wilmington, DE), were separated by SDS-PAGE and transferred onto PVDF membranes (Hybond P; Amersham Biosciences). Membranes were blocked with 5% BSA, and stained with rabbit a-ovalbumin antibody (1:1,000, ICL, UK), followed by APconjugated anti-rabbit IgG (1:7,500; Promega) and NBT/BCIP (Promega). His-tagged OVA f (see Methods S1) was used as a molecular mass marker.
GFP expression was measured by of serial dilutions of lysates using the Typhoon 8600 Imager (GE Healthcare/Amersham Biosciences, Pittsburgh, PA, USA).
Preparation of OVA-producing Bacteria and Soluble OVA for Use in DC-T cell Co-cultures Recombinant bacteria were cultured overnight with appropriate antibiotics, diluted to an OD 600 of ,0.05 and grown to an OD 600 of ,1.8 in broth. For induction of the inducible pSIP411-OVA f plasmid, 20 ng/ml SppIP (Molecular Biology Unit, University of Newcastle, UK) was added to bacterial cultures at OD 600 ,0.3. Bacteria were harvested by centrifugation, washed twice in endotoxin-free Dulbecco's PBS (PAA Laboratories, Linz, Austria), adjusted to 2610 9 bacteria/ml by counting under the microscope. To prevent bacterial replication inside APCs, the bacteria were inactivated by UV-irradiation for 18 min. The effectiveness of this treatment in killing the bacteria was confirmed by lack of bacterial growth after overnight incubation on blood agar.
Soluble OVA (Sigma) was purified of contaminating LPS using Detoxi-gel (Pierce, Rockford, IL). After this treatment, ,5 EU of LPS was present in 100 mg OVA (Chales River Endosafe test, Coatech, Kungsbacka, Sweden).
Preparation and Analysis of Antigen-presenting Cells
BALB/c mice (B&K, Sollentuna, Sweden) were sacrificed at 6-12 weeks of age. Single cell spleen suspensions were prepared and erythrocytes were lysed (0.15 M NH 4 Cl, pH 7.3, for 5 min at 37uC). CD11c
+ cells (DCs) were enriched using a-CD11c-coated magnetic MACS beads (Miltenyi Biotec, Bergisch Gladbach, Germany) and LS-columns (Miltenyi Biotec) according to the manufacturer's instructions. In some cases, CD11c + DCs were further purified by FACS-sorting (FACSAria, BD, San José, CA) using a 100 mm nozzle.
APCs were analyzed by flow cytometry (FACSCanto, BD Biosciences, Treestar, Ashland, OR) after pre-incubation with an FccR-blocking mAb and staining with antibodies against CD11c, B220, CD11b, Ly6C, MHCII, CD8a or appropriate isotype controls (BD Pharmingen, San Diego, CA).
Co-culture of Spleen APCs and OVA-specific T cells
OVA-specific T cells were purified from OVA-TCR-transgenic DO11.10 mice, whose CD4 + T cell receptor recognizes the immunodominant epitope OVA 323-339 [21] . Mice were sacrificed at 6-22 weeks of age, and the lymph nodes were excised. T cells carrying the transgenic T cell receptor were isolated using FITCconjugated anti-DO11.10 TCR antibody (KJ1-26) [22] , followed by a-FITC-conjugated MACS beads (Miltenyi Biotec). The isolation routinely resulted in .85% CD4 + KJ1-26 + cells. Unfractionated or CD11c-purified BALB/c splenocytes were used as APCs. APCs were suspended in Iscove's medium supplemented with 10% FCS, 1% L-glutamine, 1% mercaptoethanol, and 0.01% gentamycin (all from Sigma), and pulsed with UV-inactivated OVA-producing bacteria or control bacteria (5610 6 /ml or 5610 7 /ml) or with soluble endotoxin-free OVA (10 mg/ml or 100 mg/ml). For use of unfractionated spleen cells as APCs, BALB/c spleen single cell suspensions (2.5610 6 /ml) were pulsed with bacteria or OVA for 18 h, irradiated (2,500 Rad), washed, and aliquoted at 2.5610 6 cells/ml in 96-well roundbottom plates (Nunc). CD11c + cells were used at 1610 5 /ml (MACS-enriched CD11c + cells) or 2.5610 4 /ml (FACS-purified CD11c + cells) and were pulsed with bacteria or OVA for 2 h in 96-well round-bottom plates, centrifuged in the plates, and washed 63 with medium.
OVA-specific T cells were added to the antigen-pulsed APCs at 2.5610 5 cells/ml. After 4 d, supernatants were collected and proliferation was measured by [ 3 H]-thymidine incorporation (Amersham, Arlington Heights, IL). Supernatant IFN-c, IL-17, IL-10, and IL-13 concentrations were determined using DuoSet kits (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions.
Assessment of Phagocytosis
Phagocytosis of bacteria was assessed using GFP-transformed bacteria or pHrodo TM succinimidyl ester (Invitrogen) stained bacteria (0.5 mM pHrodo was used and staining was performed according to the manufacturer's instructions). The pHrodo dye was used to assess presence of bacteria in phagolysosomes, since the pH-sensitive dye emits fluorescence only in acidic environments. The APCs were incubated with fluorescent bacteria (5610 7 /ml) for 50 min at 37uC in 24-well plates (Nunc, Roskilde, Denmark). The plates were placed on ice, whereafter cells were detached using a rubber policeman, fixed in 1% paraformaldehyde (Sigma), stained with APC-conjugated a-CD11c and PerCp- conjugated a-CD11b (BD Pharmingen) and analysed by flow cytometry. Gated CD11c
+ SSC low cells that showed higher fluorescence intensities in the FL1 channel than the empty FL2 channel were regarded to be associated with GFP-producing bacteria, while cells with higher fluorescence intensities in the FL2 channel than in the FL1 (empty) channel were regarded to have internalised the pHrodo-stained bacteria.
APC Activation Marker Expression and Cytokine Production after Interaction with Bacteria
MACS-enriched CD11c
+ cells (1610 5 /ml), or unfractionated cells (2-2.5610 6 /ml), were stimulated with E. coli or Lactobacillus sakei overnight. The levels of IL-12, TNF, IL-10, and IL-6 in the culture supernatants were quantified using the Cytometric Bead Array (BD Pharmingen), PGE 2 was measured using an EIA monoclonal kit (Cayman Chemical Company, Ann Arbor, MI), and IL-1b was measured using a DuoSet kit (R&D Systems, Minneapolis, MN). CD11c + cells were analysed by flow cytometry for the expression of CD86 and CD40.
Statistical Analysis
Student's t-test was employed for comparisons of T cell proliferation and cytokine production in response to different stimuli and in response to splenic vs peritonal APCs as well as to compare mediator production by stimulated splenic and peritoneal cells. Student's paired t-test was employed to compare proliferation and cytokine production in response to OVA-expressing and non-OVA-expressing control bacteria. All reported p-values are two-sided.
Results and Discussion
OVA-expressing E. coli Activate OVA-specific T cells more Efficiently than does Soluble OVA A plasmid encoding full-length OVA protein (pIAb8A-OVA) was introduced into E. coli HB101 (see Materials and Methods). Production of OVA was confirmed by Western blotting of the sonicated bacteria (Fig. 1A) . Quantification by ELISA revealed that a sonicate of 5610 7 OVA-transformed bacteria contained 0.19 mg of OVA. The culture supernatant contained 100 times less OVA than the culture sonicate, demonstrating that E. coliproduced OVA was almost exclusively intracellular.
Unfractionated splenic APCs were pulsed for 18 h with various doses of washed and UV-killed bacteria containing OVA (E. coli-OVA), corresponding E. coli control bacteria, or soluble OVA (purified and LPS-free), after which the cells were irradiated, washed and co-cultured with OVA-specific DO11.10 CD4 + T cells. OVA-specific proliferation was calculated as the proliferative responses to the OVA-containing E. coli minus that induced by control E. coli (Dprol). Maximal proliferation was observed after 4-5 days of co-culture in response to both ''bacterial'' and soluble OVA (data not shown). Regarding antigen concentration, OVAexpressing E. coli induced maximal T-cell proliferation at 5610 7 / ml (Dprol = 12,000 cpm), while the response to the same concentration of E. coli-control was negligible (Fig. 1B) . Soluble OVA at a concentration of 100 mg/ml induced a comparable proliferative response as 5610 7 /ml OVA-producing E. coli (Fig. 1B) . Since 5610 7 bacteria contained only 0.19 mg OVA, 500-fold less E. coli-produced OVA than soluble OVA was needed to obtain the same OVA-specific T cell proliferative response.
Bacteria might be strong immunogens both because they are particles and because they express danger signals. To investigate if OVA needed to be contained within intact E. coli to be strongly immunogenic, OVA-producing E. coli were sonicated before being used in APC-T cell co-cultures. Sonication of E. coli-OVA reduced their capacity to trigger OVA-specific T cell proliferation, compared with intact E. coli-OVA (Fig. S2) . However, sonicated E. coli-OVA were still more immunogenic than the same dose of soluble OVA. We cannot exclude that the sonicate still contained quite large bacterial fragments with associated or trapped OVA. LPS and other cell wall components may also induce maturation of DCs, enabling them to more efficiently present soluble OVA. However, this might be less likely, considering the minute amounts of OVA present in the bacteria.
The spleen contains several potential APC populations including conventional and plasmacytoid DCs, monocytes, macrophages and B cells. Conventional CD11c
+ DC are regarded as the most efficient APC [23] . We enriched CD11c + cells to ,30% purity using a-CD11c-coated magnetic beads, or to .99% by flow cytometry sorting, pulsed them for 2 h with E. coli-OVA, E. colicontrol, or soluble OVA and assessed their ability to stimulate OVA-specific T cells. The CD11c
+ cells supported strong T-cell proliferation in response to both E. coli-OVA and soluble OVA, suggesting that these cells were responsible for the major APC function of spleen cells (Fig. 1D) . In contrast, FACS-sorted CD11c int B220 +
Ly6c
+ plasmacytoid DCs loaded with soluble or bacterial OVA were inefficient at activating OVA-specific T cell proliferation (Fig. 1D) .
The bacterial carrier of an antigen may, in addition to boosting proliferation, also affect whether the naïve T cells will differentiate into Th1, Th2, Th0 (mixed Th1 and Th2), or Th17 cells. We investigated signature cytokines for these T cell subsets in T cell-APC co-cultures. T cells activated by APCs pulsed with soluble OVA produced foremost the Th2 cytokine IL-13 (Fig. 1C) . In contrast, T cells responding to E. coli-OVA produced high levels of both IFN-c and IL-13, suggesting a balanced Th1/Th2 response, sometimes referred to as Th0 [24] (Fig. 1C) . The T cell cytokine pattern was very similar regardless of whether unfractionated spleen cells or CD11c + -enriched splenocytes were used as APCs (data not shown).
OVA Expressed within E. coli Induces Stronger OVAspecific CD4
+ T-cell Proliferation than OVA Expressed within Lactobacilli or Lactococci Next, we asked whether T cell activation and polarisation would differ if OVA would be expressed in G+ bacteria, rather than the G2 E. coli. The pIAb8A-OVA vector used to transform E. coli did, however, not support OVA expression in the G+ bacteria tested (data not shown). Not only do G+ and G2 bacteria require different expression plasmids, but they also use different codons for the same amino acid. To allow for comparison of T cell responses to G+ and G2 bacteria, we synthesised a gene, OVA f , encoding the amino acids 319-386 of the OVA protein but with codons optimised for expression in lactobacilli (Fig. S1 ). The OVA f gene, which contains the epitope recognised by DO11.10 T cells (a.a. 323-339), was inserted into pSIP401-based inducible or constitutive expression plasmids suitable for G+ bacteria. These constructs were transformed into the G+ lactobacilli L. sakei Lb790 and L. plantarum NC8, the lactococcus strain L. lactis MG1363, as well as the G2 E. coli XL-10. A synthetic GFP gene optimised for lactobacilli with regard to codon usage (Axelsson, L., unpublished) was inserted into the same plasmids, and bacteria transformed with these plasmids were utilised as OVA-negative control bacteria and for analysis of bacterial uptake by phagocytosis.
Semiquantitative analysis of OVA f production by Western blotting and quantification of GFP expression by fluorescence scanning of bacterial sonicates showed that both the inducible pSIP411-OVA f vector and the constitutive pSIP411p9-OVA f or -GFP vectors supported high-level expression of OVA f, as well as of GFP, in L. sakei and L. plantarum, but lower protein expression in L. lactis and E. coli (Fig. 2A, Table 2 ). This was expected, as both the vectors and the gene codon usage were optimized for expression in lactobacilli.
G+ and G2 bacteria carrying an expression plasmid for the immunodominant OVA fragment OVA f were UV-inactivated, washed and fed to unfractionated spleen APCs. After 18 h, APCs were washed, irradiated and incubated with OVA-specific DO11.10 T cells (Fig. 2B-C) . Despite the suboptimal construction of the plasmids for use in G2 bacteria, E. coli XL-10 transformed with the OVA f -plasmid induced strong OVA-specific T-cell proliferation (Fig. 2B) . In fact, the response was of similar magnitude as that induced by E. coli HB101 expressing the fulllength OVA gene (Dprol = 12,000 cpm for 5610 7 bacteria/ml) (Fig. 2B, compare with Fig. 1C ). To the contrary, both lactobacilli and lactococci transformed with OVA f , were strikingly less efficient stimulators of OVA-specific T-cell proliferation than OVA f transformed E. coli (note the different scales in the graphs in Fig. 2B and 2C) . Thus, L. sakei transformed with the inducible OVA-vector induced a significant, but weak, OVA-specific T-cell proliferation (Dprol = 400 cpm for 5610 7 bacteria/ml, and Dprol = 600 cpm for 5610 6 bacteria/ml). An OVA-specific response of similar magnitude was induced by OVA f presented in Lactococcus lactis, while no OVA-specific T cell proliferation was seen when APCs were pulsed with OVA f -transformed Lactobacillus plantarum (Fig. 2C) . This was not due to different kinetics of the response to G+ and G2 bacteria, as T cell proliferation in response to L. sakei-OVA and L. lactis-OVA was maximal day 4-5, as was the response to soluble and E. coli-expressed OVA. Furthermore, no response to L. plantarum-OVA was seen at any of the time-points tested (Days 1-7) .
The ability of transformed G+ bacteria to induce T cell proliferation did not relate to the amount of OVA produced by the strain in question. Hence, both lactobacillus strains (L. sakei and L. plantarum) produced high levels of intracellular OVA f , but L. sakei induced a measurable OVA-specific response, while L. plantarum did not. Furthermore the lactococcus strain (L. lactis) produced less OVA than did the other G+ strains (Table 2) , but induced a similar OVA-specific response as did L. sakei. Feeding more G+ bacteria to the APCs did not compensate for the poor immunogenicity, as two of the G+ strains were even less stimulatory at 5610 7 bacteria/ml than at 5610 6 bacteria/ml (Fig. 2C) . At 5610 5 bacteria/ml no OVA-specific T cell proliferation was recorded (data not shown). Similar results were obtained when using CD11c-enriched splenocytes as APCs (Fig. 3  and data not shown) .
We also assessed cytokine responses of DO11.10 cells exposed to APCs pulsed with OVA-producing G+ bacteria. L. sakei and L. lactis transformed with OVA f encoding plasmid induced some IFNg and IL-17, but no detectable IL-13 or IL-10 production (Fig. 3B and data not shown). OVA f expressing E. coli XL10 induced a mixed Th1/Th2 response dominated by IFN-g and IL-13, similar to the response seen to full-length OVA expressed by HB101 (Fig. 3A) .
Role of Phagocytosis and APC Maturation
We investigated whether poor phagocytosis was the cause of the inefficient presentation of OVA expressed intracellularly in G+ bacteria. UV-inactivated E. coli and L. sakei were stained with pHrodo, which emits fluorescence in acidic environments, such as that within the phagolysosome. Splenic DCs were allowed to interact with the labelled bacteria for 50 min, whereafter fluorescence was measured. Fluorescent E. coli were detected in 0.9860.08% of the CD11c + SSC low DCs, while L. sakei was present in 3.160.6% of the DCs. Similar results were obtained using flow cytometric analysis of GFP-expressing bacteria (not shown). As L. sakei was readily phagocytosed, inefficient uptake could not explain the low immunogenicity of the G+ bacteria.
Expression of co-stimulatory molecules on the APC surface and APC production of T cell stimulating cytokines (including IL-12) are central in stimulating T cell proliferation and maturation. The capacity of G2 (E. coli) and G+ (L. sakei) bacteria to induce APC cytokines and co-stimulatory molecules was compared.
E. coli and L. sakei both triggered upregulation of CD86 and CD40 on DCs, but considerably higher levels were induced by E. coli; this was particularly evident for CD40 (Fig. 4A) . This is in accordance with previous studies where G2 bacteria have been shown to induce DC maturation more efficiently than G+ bacteria [12, 13] . This has been linked to the ability of LPS to simultaneously activate MyD88-and TRIF-dependent pathways within DCs [25] . Exposure to LPS-free OVA did not induce any expression of co-stimulatory molecules (CD86, CD40) on DCs.
We investigated whether exposure to LPS could enhance the T cell stimulating capacity of APCs that had phagocytosed OVAexpressing G+ bacteria. Addition of LPS to the co-cultures resulted in an increased non-OVA-specific proliferation, but did not significantly enhance the OVA-specific T cell proliferation to L. sakei-OVA (data not shown). Hence, lack of DC activation could not be the only explanation to the poor immunogenicity of L. sakei, L. lactis and L. plantarum, compared to E. coli. We also addressed the possibility that G+ bacteria might actively counteract the ability of APCs to present antigens to T cells. Thus, splenic DCs were pulsed with 5610 7 E. coli-OVA/ml in the presence or absence of graded doses of L. sakei, or L. plantarum. The G+ bacteria did not significantly alter the OVA-specific T cell activation in response to E. coli-OVA (Fig. 4B) .
Next, splenic APCs were tested for production of cytokines in response to overnight incubation with E. coli and L. sakei. As seen in Table 3 , L. sakei induced at least as much IL-12, TNF and IL-6 as did E. coli. Stimulation with E. coli induced a higher production of IL-10 than L. sakei (Table 2 ), but since IL-10 would rather counteract T cell activation [26] , the presence of IL-10 cannot explain the higher T cell stimulatory capacity of APCs pulsed with G2 than G+ bacteria. Exposure of splenocytes to soluble OVA for 16 h did not result in the production of any of the investigated cytokines (IL-12, TNF, IL-6 ). Since soluble OVA, that did not Figure 1 . OVA-specific T-cell responses to OVA produced intracellularly in E. coli. E. coli HB101 was transformed with the pIAb8A-OVA plasmid encoding full-length ovalbumin (OVA), or an empty pIAb8A-control plasmid. A, Western blot showing presence of OVA in sonicates of the transformed bacteria; OVA = soluble OVA standard. B, Proliferative responses of OVA-specific transgenic DO11.10 T cells co-cultured for 4 d with irradiated splenocytes pulsed with E. coli-OVA, E. coli-control or soluble OVA (n = 6 mice for 5610 7 /ml bacteria and 100 mg/ml OVA; n = 2 for the other concentrations). C, Production of cytokines in 4 d co-cultures of OVA-specific T cells and CD11c activate APCs, induced IL-13 producing T cells, one may speculate that Th2 polarization is the default T cell maturation pathway induced by non-activated splenic APC. In contrast, when cytokines such as IL-12 and TNF and co-stimulatory molecules are induced by bacterial stimulation, this favours Th1 maturation and production of IFN-. In accordance, bacteria induced maturation of monocyte derived DC has been shown to favour Th1 polarisation to presented unrelated antigens [13, 14, 15] .
From our results it seems that poor uptake could not explain the inefficient presentation of an intracellular protein in G+ bacteria and that lack of LPS might contribute, but not fully explain this defect. An alternative explanation may be inefficient loading of Figure 2 . OVA-specific T-cell responses to OVA fragment 319-386 produced intracellularly in E. coli, lactobacilli and lactococci. Lactobacillus sakei, Lactobacillus plantarum, Lactococcus lactis, and E. coli were transformed with vectors encoding an immunodominant OVA fragment (OVA f ). A, Western blot showing production of OVA f by L. sakei and E. coli; expression is lower in E. coli due to use of a vector optimal for G+ bacteria. His-tagged OVA f was used as a molecular mass marker (one representative experiment of three). Proliferative responses of DO11.10 T cells stimulated with irradiated splenocytes pulsed with OVA f -transformed E. coli (B), or lactobacilli/lactococci (C). Despite lower expression of OVA f in E. coli, OVA-specific proliferation is much more pronounced in cultures with transformed E. coli than in cultures with transformed lactobacilli/lactococci; note the different scales in the respective graphs (n = 5 for E. coli and L. sakei; n = 3 for L. plantarum and L. lactis). * P,0.05; ** P,0.01. doi:10.1371/journal.pone.0065124.g002 peptides on MHC II molecules. The G+ cell wall is much thicker (.50 layers of peptidoglycan), more sturdy and tighter meshed than the cell wall of G2 bacteria, which often have a single sparsely cross-linked peptidoglycan layer. Break-down of G+ bacteria in the phagolysozome is therefore a more demanding task than lysis of G2 bacteria. Thus, the rigid cell wall of G+ bacteria may delay the release of OVA in the APC after internalization. One may also speculate that, compared to easily digestible G2 bacteria, the presence of poorly digestible G+ bacteria within the phagosome triggers a stronger lysosomal maturation, the process whereby lysozyme (which degrades cell wall peptidoglycan), proton pumps and bacteria-degrading enzymes are recruited into the phagosome. As it takes longer time to digest a G+ than a G2 bacterium, higher concentrations of proteolytic enzymes may accumulate, resulting in a more extensive degradation of bacterial proteins, including OVA. Thus, in the highly proteolytic environment, the peptides from Gram-positive bacteria may become too degraded for loading onto MHC II. In support of the theory of inefficient loading of proteins present within bacteria with a rigid cell wall, the cell wall of L. plantarum is more resistant to digestion with lysozyme, compared to those of L. sakei and L. lactis (Axelsson, L., unpublished observation). Despite being produced in high levels, OVA expressed within L. plantarum was presented least efficiently by APCs to T cells. Notably, pulsing APCs with sonicates of G+ bacteria did not induce any OVA-specific T cell activation (unpublished observations), suggestedly because soluble bacterial constituents are taken up less efficiently than intact bacteria. In addition, sonicated G+ bacteria have been shown to trigger less APC activation, compared to intact G+ bacteria [27] .
In summary, we demonstrate a striking difference in efficiency of antigen presentation to CD4 + T cells when an antigen (OVA) was present in its soluble form or expressed in G2 or G+ bacteria. The expression of OVA in E. coli led to efficient immunogenic presentation to OVA-specific T cells, hence 500-fold less ''bacterial OVA'' than soluble OVA was needed to induce the same magnitude of T cell proliferation. We could also demonstrate a shift in T cell maturation pathways, from a Th2 to a mixed Th1/ Th2 phenotype when DCs had been incubated with OVA expressed within E. coli, compared to soluble OVA. Despite producing large amounts of OVA and despite being efficiently phagocytosed, G+ bacteria were, compared with G2 bacteria, inefficient vehicles for the delivery of immunogenic protein to antigen-presenting cells. The results suggest that intracellular expression of proteins within G+ bacteria conveys poor immunogenicity, which may be taken into account when considering G+ bacteria as vehicles for vaccine delivery. Table 3 . Cytokine production by bacteria-stimulated splenocytes (n = 5, mean 6 SEM).
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